Drug intelligence / Profile preview

rabies human immunoglobulin (Zhejiang Haikang Biological Products)

Development stage
Preclinical
Lead developer
Zhejiang Haikang Biological Products
Modality
Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
Administration
Intramuscular, Local Infiltration
01

Overview

Rabies human immunoglobulin (HRIG) is a plasma-derived biologic developed by Zhejiang Haikang Biological Products for rabies post-exposure prophylaxis. It contains high titers of neutralizing antibodies against the rabies virus, obtained from the plasma of hyperimmunized human donors. The product is designed to provide immediate passive immunity to individuals exposed to rabies, neutralizing the virus at the site of infection and preventing its progression to the central nervous system during the window before active immunity from rabies vaccination is established. It is intended for administration via local wound infiltration and intramuscular injection.

Other names
狂犬病人免疫球蛋白Human Rabies ImmunoglobulinHRIG
02

Targets

RABV-G (Rabies virus glycoprotein)

Beyond the preview

Go deeper on rabies human immunoglobulin (Zhejiang Haikang Biological Products).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rabies human immunoglobulin (Zhejiang Haikang Biological Products).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call